Mark W. Sawicki net worth and biography

Mark Sawicki Biography and Net Worth

Insider of Cryoport
Mark Sawicki brings 15 years of business development and sales management experience, having consistently delivered on corporate revenue and market share goals in the pharmaceutical and biotechnology industries. Sawicki was most recently the chief business officer at AAIPharma Services Corporation/Cambridge Major Laboratories Inc. Additionally, he has served in senior business development roles at CMC Biologics and Albany Molecular Research Inc. (AMRI), where he increased revenue at rates far outpacing industry standards. Sawicki holds a bachelor’s in biochemistry from the State University of New York at Buffalo and a Ph.D. in biochemistry from the State University of New York at Buffalo, School of Medicine and Biomedical Sciences. He also received graduate training at the Hauptman Woodard Medical Research Institute. Sawicki has authored a dozen scientific publications in drug discovery with a focus on oncology and immunology.

What is Mark W. Sawicki's net worth?

The estimated net worth of Mark W. Sawicki is at least $1.43 million as of March 15th, 2023. Dr. Sawicki owns 61,670 shares of Cryoport stock worth more than $1,428,894 as of March 31st. This net worth approximation does not reflect any other investments that Dr. Sawicki may own. Learn More about Mark W. Sawicki's net worth.

How do I contact Mark W. Sawicki?

The corporate mailing address for Dr. Sawicki and other Cryoport executives is 112 Westwood Place Suite 350, Brentwood TN, 37027. Cryoport can also be reached via phone at (949) 470-2300 and via email at [email protected] Learn More on Mark W. Sawicki's contact information.

Has Mark W. Sawicki been buying or selling shares of Cryoport?

Over the course of the past ninety days, Mark W. Sawicki has sold $58,042.62 of Cryoport stock. Most recently, Mark W. Sawicki sold 1,362 shares of the business's stock in a transaction on Wednesday, March 15th. The shares were sold at an average price of $20.79, for a transaction totalling $28,315.98. Following the completion of the sale, the insider now directly owns 61,670 shares of the company's stock, valued at $1,282,119.30. Learn More on Mark W. Sawicki's trading history.

Who are Cryoport's active insiders?

Cryoport's insider roster includes Richard Berman (Director), Daniel Hancock (Director), Mark Sawicki (Insider), Jerrell Shelton (CEO), Robert Stefanovich (CFO), and Edward Zecchini (Director). Learn More on Cryoport's active insiders.

Are insiders buying or selling shares of Cryoport?

During the last twelve months, insiders at the consumer goods maker sold shares 9 times. They sold a total of 23,421 shares worth more than $579,611.22. The most recent insider tranaction occured on March, 15th when insider Mark W Sawicki sold 1,362 shares worth more than $28,315.98. Insiders at Cryoport own 9.7% of the company. Learn More about insider trades at Cryoport.

Information on this page was last updated on 3/15/2023.

Mark W. Sawicki Insider Trading History at Cryoport

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/15/2023Sell1,362$20.79$28,315.9861,670View SEC Filing Icon  
3/13/2023Sell1,476$20.14$29,726.6463,032View SEC Filing Icon  
3/9/2022Sell1,410$31.05$43,780.50View SEC Filing Icon  
3/10/2021Sell13,331$55.13$734,938.0330,342View SEC Filing Icon  
See Full Table

Mark W. Sawicki Buying and Selling Activity at Cryoport

This chart shows Mark W Sawicki's buying and selling at Cryoport by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cryoport Company Overview

Cryoport logo
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.
Read More

Today's Range

Now: $23.64
Low: $22.75
High: $23.64

50 Day Range

MA: $22.08
Low: $19.18
High: $25.86

2 Week Range

Now: $23.64
Low: $15.63
High: $45.36


33,573 shs

Average Volume

407,117 shs

Market Capitalization

$1.14 billion

P/E Ratio


Dividend Yield